NeoGenomics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
NEO Key Statistics
Stock Snapshot
NeoGenomics(NEO) stock is priced at $16.66, giving the company a market capitalization of 2.14B. It carries a P/E multiple of -41.27.
On 2026-10-19, NeoGenomics(NEO) stock moved within a range of $16.44 to $17.45. With shares now at $16.66, the stock is trading +1.3% above its intraday low and -4.5% below the session's peak.
Trading activity shows a volume of 2.31M, compared to an average daily volume of 2.39M.
The stock's 52-week range extends from a low of $7.07 to a high of $20.15.
The stock's 52-week range extends from a low of $7.07 to a high of $20.15.
NEO News
...
NeoGenomics (NEO) has expanded its partnership with Indica Labs. The collaboration is intended to scale NeoGenomics’ digital pathology infrastructure and accele...
NeoGenomics (NEO) is back in focus after the board mapped out a CEO handover to current President and COO Warren Stone and reaffirmed and then flagged an expect...
Analyst ratings
75%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.